100 related articles for article (PubMed ID: 34530993)
21. Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population.
Saadi AV; Gupta H; Angural A; Dhanya SK; Mony S; Oberoi D; D'Souza SC; Sahoo RC; Hande MH; Gopinath PM; Satyamoorthy K
Infect Genet Evol; 2013 Dec; 20():140-7. PubMed ID: 24012958
[TBL] [Abstract][Full Text] [Related]
22. Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India.
Annamaneni S; Gorre M; Kagita S; Addepalli K; Digumarti RR; Satti V; Battini MR
Hematology; 2013 May; 18(3):163-8. PubMed ID: 23320983
[TBL] [Abstract][Full Text] [Related]
23. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
[TBL] [Abstract][Full Text] [Related]
24. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.
Baechler BL; Bloemberg D; Quadrilatero J
Autophagy; 2019 Sep; 15(9):1606-1619. PubMed ID: 30859901
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
26. P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study.
Rovira A; Urbano-Ispizua A; Cervantes F; Rozman M; Vives-Corrons JL; Montserrat E; Rozman C
Ann Hematol; 1995 Mar; 70(3):129-33. PubMed ID: 7718641
[TBL] [Abstract][Full Text] [Related]
27. Investigation of Caspase 9 Gene Polymorphism in Patients With Non-small Cell Lung Cancer.
Ercan S; Arinc S; Yilmaz SG; Altunok C; Yaman F; Isbir T
Anticancer Res; 2019 May; 39(5):2437-2441. PubMed ID: 31092436
[TBL] [Abstract][Full Text] [Related]
28. Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea.
Azevedo AP; Silva SN; Reichert A; Lima F; Júnior E; Rueff J
Mol Med Rep; 2018 Dec; 18(6):5243-5255. PubMed ID: 30320340
[TBL] [Abstract][Full Text] [Related]
29. Polymorphic variants of Caspase genes (8 & 3) in the risk prediction of Coronary Artery Disease.
Gundapaneni KK; Shyamala N; Galimudi RK; Kupsal K; Gantala SR; Padala C; Gunda P; Tupurani MA; Puranam K; Sahu SK; Hanumanth SR
Gene; 2017 Sep; 627():278-283. PubMed ID: 28633917
[TBL] [Abstract][Full Text] [Related]
30. MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia.
Lardo M; Castro M; Moiraghi B; Rojas F; Borda N; Rey JA; Lazarowski A
Blood Res; 2015 Sep; 50(3):154-9. PubMed ID: 26457282
[TBL] [Abstract][Full Text] [Related]
31. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
32. The Association of rs2114358 in the miR-1206 Polymorphism to Chronic Myeloid Leukemia.
Hassan FM
Microrna; 2019; 8(3):248-252. PubMed ID: 30605069
[TBL] [Abstract][Full Text] [Related]
33. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib.
Vivona D; Bueno CT; Lima LT; Hirata RD; Hirata MH; Luchessi AD; Zanichelli MA; Chiattone CS; Guerra-Shinohara EM
Blood Cells Mol Dis; 2012 Feb; 48(2):132-6. PubMed ID: 22134106
[TBL] [Abstract][Full Text] [Related]
34. Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.
Salimizand H; Amini S; Abdi M; Ghaderi B; Azadi NA
Tumour Biol; 2016 Jan; 37(1):791-8. PubMed ID: 26250462
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia.
Kim DH; Xu W; Ma C; Liu X; Siminovitch K; Messner HA; Lipton JH
Blood; 2009 Mar; 113(11):2517-25. PubMed ID: 19141860
[TBL] [Abstract][Full Text] [Related]
36. [Association of CASP3 and CASP9 polymorphisms with genetic susceptibility to stomach cancer].
Ni Q; Jiang X; Jin MJ; Liu B; Chen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):318-22. PubMed ID: 21644232
[TBL] [Abstract][Full Text] [Related]
37. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
[TBL] [Abstract][Full Text] [Related]
38. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
[TBL] [Abstract][Full Text] [Related]
39. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
40. Transformation of Chronic Myeloid Leukemia to Acute Biphenotypic Leukemia.
Ivanov S; Sharma P; Jobanputra Y; Zhang Y
J Med Cases; 2020 Aug; 11(8):239-242. PubMed ID: 34434403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
